Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Your Pharma Contract Is Approved. But Is It A Competitive Deal?
Nithin Mummaneni is the founder and CEO of Infinity Loop. A 300-page pharmaceutical outsourcing agreement can clear legal, quality, regulatory and technical review without anyone asking whether the price is competitive. Each department…
Laprophan Raises $223 Million in Africa's Largest Pharma IPO
Laprophan raised 2.22 billion dirhams ($223 million) in an initial public offering on the Casablanca stock exchange, the largest flotation by an African pharmaceutical company. The Moroccan firm sold 6.52 million existing and new shares at 341…
Avalyn Pharma: The Tolerability Budget Is The Real Battleground In Pulmonary Fibrosis
Avalyn Pharma offers lung-directed delivery of proven antifibrotics, potentially preserving tolerability as IPF and PPF regimens incorporate additional systemic agents. AP01 targets PPF label expansion, while AP02 and combination candidate AP03…
Johnson Winter Slattery guides on acquisition of women's health specialist pharma company
The acquisition will boost the buyers' position within the women's health sector in Europe and globally. Australian law firm Johnson Winter Slattery has advised pharmaceutical manufacturer Gedeon Richter on its acquisition of Mayne Pharma Group via…
Pharma leaders rate ability to act on diagnostic insights just 5.2/10, Diaceutics survey finds
Pharmaceutical companies are struggling to translate diagnostic intelligence into coordinated action that helps eligible patients reach appropriate treatment, according to new research from intelligence and engagement company, Diaceutics. The…
3 Big Pharma Dividend Stocks Built for Retirement Income
A retirement portfolio needs income that holds up through patent cliffs, and the world's largest drugmakers have spent decades replacing old blockbusters with new ones while the dividend checks keep coming. Bristol Myers Squibb (NYSE:BMY | BMY…
Spyglass Pharma (NASDAQ:SGP) Shares Gap Down - Here's Why
Spyglass Pharma, Inc. (NASDAQ:SGP - Get Free Report) shares gapped down prior to trading on Thursday. The stock had previously closed at $31.43, but opened at $29.73. Spyglass Pharma shares last traded at $28.47, with a volume of 5,982 shares…
Pharmalittle: We're reading about a Merck AI deal, China and the pharma supply chain, and more
Rise and shine, everyone, another busy day is on the way. And it is getting off to a pleasant start here on the Pharmalot campus, where clear blue skies and comfy breezes are greeting us. As for the official mascots, they have finished keeping…
Urogen Pharma (NASDAQ:URGN) Stock Price Up 6.8% - Still a Buy?
Urogen Pharma (NASDAQ:URGN - Get Free Report)'s stock price rose 6.8% on Thursday. The company traded as high as $31.83 and last traded at $31.8150. 317,146 shares were traded during mid-day trading, a decline of 64% from the average daily volume…
Piramal Pharma acquisition: Company to buy remaining 26% stake in Yapan Bio
Updated - November 19, 2026 at 09:36 AM. Piramal Pharma Limited said it would acquire the remaining 26 per cent equity stake in Yapan Bio Private Limited, a subsidiary of the company, from its existing shareholders. The administrative committee…
Nuvectis Pharma (NASDAQ:NVCT) Shares Gap Up - Should You Buy?
Nuvectis Pharma, Inc. (NASDAQ:NVCT - Get Free Report)'s share price gapped up prior to trading on Thursday. The stock had previously closed at $19.20, but opened at $20.48. Nuvectis Pharma shares last traded at $20.2750, with a volume of 7,363…
365,074 Royalty Pharma PLC $RPRX Shares Sold by Aberdeen Group plc
Aberdeen Group plc trimmed its position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 63.1% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 213,127 shares of the…
Zurich University Hospital performs brain surgery using a hologram
The precise placement of what is known as an external ventricular catheter in a patient's brain has, until now, been a major challenge, the Zurich University Hospital stated on Thursday. The thin tube must be inserted into a ventricle of the brain…
WEF role 'option' for Lagarde after leaving ECB
“It's one of the options,” she said at the New York Times DealBook Summit. “But for the moment, I'm the president of the European Central Bank, and will be so until Febuary 7. And I'm not going to entertain any sort of…
Swiss exports pick up in October
Once again, it was the chemicals and pharmaceuticals sector that drove international sales, while the jewellery sector saw a decline. Exports surged by 6.3% month-on-month and in nominal terms (unadjusted for inflation) to CHF24.7 billion ($29.3…
Receive a Daily briefing on Pharma Industry News
Get Started